The power of ideas through the development of innovative research tools
- CQDM and the Massachusetts Life Sciences Center announce a new international partnership program
- CQDM receives funding of $ 11.7 M from the Federal Government
- CQDM welcomes Novartis as a new contributing member to the Explore Program
- Diane Gosselin appointed President and Chief Executive Officer of CQDM
The Québec Consortium for Drug Discovery (CQDM) is a meeting ground for all stakeholders in biopharmaceutical research and whose principal mission is to fund research projects carried out in partnership between the academic and hospital milieus in the public sector and the pharmaceutical and biotechnology industries in the private sector.
An innovative Canadian initiative, CQDM has a twofold goal: to accelerate the drug discovery process and to develop safer and more effective drugs.
Established under an innovative public-private partnership model, CQDM puts the needs of the pharmaceutical industry at the very centre of its concerns.